Lenzing's €300 Million Rights Issue Sends Shares to a 52-Week Low as Berenberg Steps Back

Lenzing stock fell 28% to €14.02 as investors weighed a €300 million rights issue at €8.65 per share, a 42.50% discount to the ex-rights price.

Lenzing shareholders endured a brutal Friday session, with the stock collapsing 28% to €14.02 as the market digested the terms of a fully guaranteed rights offering launched a day earlier. The selloff pushed the shares to a fresh 52-week trough of €13.84 intraday, capping a week in which the Austrian fibre producer's capital-raising plans moved from announcement to execution.

At the heart of the turmoil is a cash call designed to raise roughly €300 million in gross proceeds through the issuance of 34,756,362 new shares. The subscription ratio stands at 10-for-9, and the offer price of €8.65 per share represents a 42.50% discount to the theoretical ex-rights price calculated from the 30 September closing level. That gap between market value and issue price is precisely what has investors recalibrating their positions.

The repricing began before Friday's rout. On Thursday, the day Lenzing formally kicked off the transaction, the stock shed 6.2% to close at €19.42. The scale of the discount has left existing holders facing a straightforward choice: commit fresh capital, sell their subscription rights, or accept significant dilution.

Analysts Turn Cautious as Suzano Holds Back

The sharp move drew an immediate response from the research community. Berenberg downgraded the stock from "Buy" to "Hold" and trimmed its price target, citing not only the capital measure itself but also a wait-and-see stance from major shareholder Suzano. Raiffeisen analysts likewise flagged dilution concerns tied to the new share issue, according to a report by n-tv, adding to the selling pressure that weighed on the stock throughout the session.

The transaction does carry an unusually strong backstop. Anchor shareholders have made irrevocable commitments to exercise their full entitlements: both the B&C Group and Brazil's Suzano, alongside Oberbank, have pledged to take up their rights. That full guarantee underpins the deal's structure and, if the cash inflow lands as planned, should meaningfully strengthen Lenzing's equity profile.

The proceeds are earmarked for the company's "Grow Nonwovens, Reset Textiles" realignment and for restoring balance-sheet stability. Whether €300 million is enough to complete that transformation without further capital injections remains the central question for valuation.

Dilution Cuts Both Ways

For shareholders unable or unwilling to participate, the arithmetic is unforgiving. The new issuance nearly doubles the number of shares outstanding, sharply reducing existing holders' proportional stakes, voting power and claim on future earnings. Heavy selling of subscription rights into the market could depress the price of the rights themselves, which in turn would drag on the common stock as traders arbitrage the gaps between old shares, rights and the new paper.

The macroeconomic backdrop offers little comfort either. Even a smooth completion of the recapitalisation does not guarantee an operational turnaround if demand in core textile markets stays subdued for an extended period.

Key Dates and the Rights Trading Window

The coming sessions will determine which scenario plays out. So long as the share price holds well above the €8.65 subscription level, the economic incentive to exercise rights stays high. Should sentiment sour and the quotation drift toward that mark, the rights market could come under heavy selling pressure.

The provisional timetable is set. Rights trading on the Vienna Stock Exchange runs from 6 to 14 October, while the subscription period for the new shares opens on Tuesday, 6 October and closes on 20 October. Settlement, delivery and the first day of trading in the new shares are scheduled for 23 October, subject to registration of the capital increase in the commercial register. Only then will the market's lasting verdict on the reshaped ownership structure and recapitalised balance sheet become clear.

Plant Sale Draws Crowds

Running alongside the financial engineering, management continues to reshape its industrial footprint. The Lyocell plant in Heiligenkreuz, Burgenland, which is up for sale, has attracted interest from more than 30 prospective buyers, according to media reports. Formal bids are due to begin this month.